In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...
In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee ...
12 小时on MSN
Not all fat is the same... where yours collects could signal increased risk of an array of ...
Obesity has long been known as a risk factor for a host of diseases like cancer and dementia, but researchers now say that ...
A real weight loss drug, called retatrutide, is currently being developed by pharmaceutical giant Eli Lilly, but there has ...
212Pb-DOTAMTATE showed significant antitumor activity in PRRT-exposed GEP-NETs, with a 34.6% objective response rate and 96.2% disease control rate. The 18-month progression-free survival and overall ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果